Who are the best prospects of the 2022 NFL draft class? Scouts Inc. powers ESPN's DraftCast rankings, and its board goes hundreds of prospects deep every year. Here is the full list for 2022, along ...

How was the shortlist selected? The initial shortlist of players was selected by the UEFA technical study group based on their performance during the 2022/23 season at both club and national team ...

World Report 2022, Human Rights Watch’s 32nd annual review of human rights trends around the globe, reviews developments in more than 100 countries. In his introductory essay, Executive Director ...

A woman casts her ballot in the midterm elections at Fox Theatre in Atlanta on Nov. 8, 2022. (Michael M. Santiago/Getty Images) After soaring in 2018 compared with the previous midterm, voter turnout ...

Apple continues to be the top-selling smartphone vendor in the world, with iPhone lines occupying eight of the top ten in global sales rankings for 2022. Apple's iPhone lineup has consistently been ...

The Chiefs finished the final chapter of the 2022 NFL season, but we all know there's never a dull stretch on the NFL calendar. Before the NFL combine is the appropriate time to take in everything we ...

We are on the brink of wrapping up the fifth season of the RB Index, but I'm about to enter some new territory. I've decided to rank every running back who started a game in the 2022 NFL season. Here ...

Pfizer sold $37.8 billion of its Covid vaccine last year, a small increase of 3% compared with 2021 as demand for the shots slowed. Sales of Paxlovid, however, surged to $18.9 billion in 2022, which ...

For a time during the fourth quarter, it looked like help was on the way for investors after a brutal first three quarters of the year. But by the end of 2022, relief over a potential slowing in ...

2022 was a tumultuous year for global capital markets, which had to contend with a range of geopolitical and economic headwinds after the Covid-era fallout. Inflation measures reached 40-year highs ...

Last year the FDA’s Center for Drug Evaluation and Research (CDER) approved 37 novel drugs. This is a drop from the highs of the past 5 years, and brings the rolling 5-year average down to 49 drugs ...

The past year was one for the record books. Unfortunately, for the most part, those were record losses, for the worst returns going back many years. For posterity’s sake, and a little bit of morbid ...